ABU-SHAAR, MUNA   DECHERT LLP
15
Patents represented
Technical areasPatents
Biotechnology10
Pharmaceuticals5
Medical technology1

Countries of applicants

Summary

ABU-SHAAR, Muna is very experienced in the technologies „Biotechnology“ and „Pharmaceuticals“. 87% of all patents are related to „(Bio)Chemistry“. Most important clients are „ABBOTT BIOTHERAPEUTICS CORP.“ and „PROTEON THERAPEUTICS, INC.“. ABU-SHAAR, Muna was very active in 2011 and 2010. Oftentimes, clients are from United States.

Patents by year

Patents by area

1
Patent applications
13
Patent applications

Patents by applicant

RankNameCountryPatents
1ABBOTT BIOTHERAPEUTICS CORP.United States5
2PROTEON THERAPEUTICS, INC.United States2
3UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCEUnited States2
4ABBVIE BIOTHERAPEUTICS INC.United States1
5CLEVELAND CLINICUnited States1
6KELLBENX INCORPORATEDUnited States1
7MESOTEX, INC.United States1
8SONOMACEUTICALS, LLCUnited States1
9THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTUREUnited States1
10UNIVERSITY OF KANSASUnited States1

Latest patents

Publication numberTitlePatent applicantYear
WO2016178931PROCESS FOR SEPARATING NUCLEATED CELLS FROM NON-NUCLEATED RED BLOOD CELLSMESOTEX, INC.
2016
WO2016022472MAMMALIAN PLURIPOTENT STEM CELLS, METHODS FOR THEIR PRODUCTION, AND USES THEREOFUNIVERSITY OF KANSAS
2016
WO2015175562PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCS) FOR DIAGNOSTIC TESTINGKELLBENX INCORPORATED
2015
WO2014144935ANTI-CD25 ANTIBODIES AND THEIR USES2014
WO2014047222METHODS FOR IDENTIFYING ANTIBODIES WITH REDUCED IMMUNOGENICITYABBVIE BIOTHERAPEUTICS INC.
2014
WO2013165921THERAPEUTIC USE OF CHARDONNAY SEED PRODUCTSTHE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE
SONOMACEUTICALS, LLC
2013
WO2011113019CTLA4 PROTEINS AND THEIR USESABBOTT BIOTHERAPEUTICS CORP.
2011
WO2011059762ANTI-EGFR ANTIBODIES AND THEIR USESABBOTT BIOTHERAPEUTICS CORP.
2011
WO2011053321USE OF AUTOLOGOUS EFFECTOR CELLS FOR TREATMENT OF MULTIPLE MYELOMAUNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCE
2011
WO2011053322USE OF AUTOLOGOUS EFFECTOR CELLS AND ANTIBODIES FOR TREATMENT OF MULTIPLE MYELOMAUNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCE
2011
WO2010148223ANTI-VEGF ANTIBODIES AND THEIR USESABBOTT BIOTHERAPEUTICS CORP.
2010
WO2010121140ANTI-TNF-α ANTIBODIES AND THEIR USESABBOTT BIOTHERAPEUTICS CORP.
2010
WO2010051391USE OF ANTI-CS1 ANTIBODIES FOR TREATMENT OF RARE LYMPHOMASABBOTT BIOTHERAPEUTICS CORP.
CLEVELAND CLINIC
2010
WO2009097621MEDICAL DEVICEPROTEON THERAPEUTICS, INC.
2009
WO2009079220RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOFPROTEON THERAPEUTICS, INC.
2009